UCB License Grant Clause Samples
UCB License Grant. UCB hereby grants to AMYLIN a perpetual, irrevocable, worldwide, fully paid-up royalty-free license under UCB Technology, with the right to grant sublicenses within the limits defined in Article 8.2 hereunder, to make, have made, use, import, offer to sell, have sold and sell peptide amylin agonists including
UCB License Grant. UCB hereby grants to AMYLIN a perpetual, irrevocable, worldwide, fully paid-up royalty-free license under UCB Technology, with the right to grant sublicenses within the limits defined in Article 8.2 hereunder, to make, have made, use, import, offer to sell, have sold and sell peptide amylin agonists including pramlintide. This license shall be exclusive (even as to UCB and its Affiliates) from the Effective Date through the later of (i) ten (10) years from the Launch Date, and (ii) the date when the last patent covering UCB Technology expires, except that during such exclusive period, UCB shall retain rights to make Product for AMYLIN pursuant to the terms of this Agreement. The license granted above in this Paragraph 8.1 shall become a non-exclusive license following the period of exclusivity stated above.